Mike Philbrick
Healthcare Leaders Income ETF
HHL-T
PAST TOP PICK
Jan 21, 2025
(A Top Pick Jan 26/24, Up 12%)
The unhedged stock. Is covered call, boosting yield. Healthcare stocks have sold off, like Eli Lilly, though ISRG has done well. Is a lot of change in healthcare amid the change in presidents. So, this sector is sadly on the back burner. If you hold it, you get paid a good dividend as you wait.
Healthcare sector lagging in the market, and is due for an increase in value. Very large companies with tailwind in aging population/demand for healthcare. Covered call strategy adds to yield. Good option for investors going forward.
Blue-chip basket of US healthcare names. Covered calls and leverage. Covered calls trade potential upside for potential income. If investor's ACB has gone down, could be because of return of capital.
Great option for income oriented investors. However, would recommend diversifying with other names in portfolio. Overall direction of healthcare sector is strong.
A good product that can be held. Would recommend as a portion of portfolio. Not a capital appreciation strategy - covered call reduces ability for share to appreciate.
It has had the same distribution for the past 10 years and is one of the top performers in the market. It has equity risk with some volatility but pays a consistent monthly distribution. Holds 20 large cap companies with maybe only a couple of changes per year.
The unhedged stock. Is covered call, boosting yield. Healthcare stocks have sold off, like Eli Lilly, though ISRG has done well. Is a lot of change in healthcare amid the change in presidents. So, this sector is sadly on the back burner. If you hold it, you get paid a good dividend as you wait.